Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
10/13/2010 | EP2239272A2 Specific protein of the pancreatic beta cells of the Langerhans' islands and applications thereof |
10/13/2010 | EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction |
10/13/2010 | EP2239253A1 Novel phenylpyrrole derivative |
10/13/2010 | EP2239012A2 Pharmaceutical use of substituted amides |
10/13/2010 | EP2238987A1 Sugar chain-related gene and use thereof |
10/13/2010 | EP2238970A1 Emulsion preparation for external application to skin and cosmetic preparation |
10/13/2010 | EP2238969A1 Preparation for external application to skin and cosmetic preparation |
10/13/2010 | EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
10/13/2010 | EP2237779A1 Benzothiazole and benzoxazole derivatives and methods of use |
10/13/2010 | EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors |
10/13/2010 | EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs |
10/13/2010 | EP1487967B1 Chimeric pancreas |
10/13/2010 | CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes |
10/13/2010 | CN1972918B Pyrimidine derivatives |
10/13/2010 | CN1931258B Preparation process and use of loquat seed extract |
10/13/2010 | CN1927202B Vitamin E nicotinate microcapsule and its preparing process |
10/13/2010 | CN1919207B Gariic and medlar capsule |
10/13/2010 | CN1761465B Method for manufacturing coated formulation |
10/13/2010 | CN1628829B Chinese medicine for treating hypertension, high blood fat and high blood sugar |
10/13/2010 | CN1395581B Recombinant antibodies to human IL-1 beta |
10/13/2010 | CN101861311A 5-pyridinone substituted indazoles |
10/13/2010 | CN101861303A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
10/13/2010 | CN101861149A N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
10/13/2010 | CN101857646A Method for extracting high-purity beta-glucan and whole oat flour from oat bran |
10/13/2010 | CN101857642A Polysaccharide derivative and vanadium complex application thereof |
10/13/2010 | CN101857636A Anti-interferon-alpha antibodies |
10/13/2010 | CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof |
10/13/2010 | CN101857554A Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase |
10/13/2010 | CN101857542A Method for manufacturing low-lead granular zinc citrate |
10/13/2010 | CN101856471A Chinese medicinal composition for tonifying kidney and strengthening body |
10/13/2010 | CN101856458A Chinese medicament for treating diabetes mellitus |
10/13/2010 | CN101856450A Chinese medicinal composition for treating diabetic nephropathy |
10/13/2010 | CN101856448A Chinese medicament for treating diabetes mellitus |
10/13/2010 | CN101856439A Chestnutsdispe capsule and preparation method thereof |
10/13/2010 | CN101856437A Chinese medicament for treating hyperlipidemia |
10/13/2010 | CN101856433A Application of Puer tea in preparing dugs for preventing oxidative stress caused by immunosenescence or other relevant disease thereof |
10/13/2010 | CN101856432A Preparation method of chitosan nanoparticles encapsulated tea polyphenol |
10/13/2010 | CN101856405A Medicinal composition for treating type II diabetes mellitus and preparation method thereof |
10/13/2010 | CN101856399A Application of white peony root extract in preparing medicament for treating diabetes mellitus |
10/13/2010 | CN101856390A Slimming Chinese traditional medicament ointment |
10/13/2010 | CN101856389A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and application thereof |
10/13/2010 | CN101856383A Liver-protecting white spirit and preparation method thereof |
10/13/2010 | CN101856382A Novel method for extracting and separating platycodin effective ingredients |
10/13/2010 | CN101856369A Stachyose tablets for calcium supplementation and intestinal micro-ecological regulation |
10/13/2010 | CN101856367A Preparation method of chicken bone paste zymolyte with antioxidant activity |
10/13/2010 | CN101856354A Novel composition for reducing blood sugar |
10/13/2010 | CN101856351A Composition and use thereof in preparation of RXR receptor transcription inhibitor |
10/13/2010 | CN101856342A Pravastatin transdermal administration preparation and preparation method thereof |
10/13/2010 | CN101856339A Controlled release dosage form and preparation method thereof |
10/13/2010 | CN101597389B Mixture of momordica saponins and polysaccharides and extraction process and application thereof |
10/13/2010 | CN101496580B Special diet and foodstuffs formula containing small peptide for diabetic |
10/13/2010 | CN101491499B Composite liposome for injection containing 12 vitamins and preparation method thereof |
10/13/2010 | CN101376016B Method for preparing Chinese medicine for treating hyperlipemia |
10/13/2010 | CN101357156B Traditional Chinese medicine for curing diabetes and preparation method thereof |
10/13/2010 | CN101258875B Yoghourt useful for lowering blood fat and preparation |
10/13/2010 | CN101180047B Use of cyclodextrin complexes containing lipoic acid |
10/13/2010 | CN101152233B Pharmaceutical composition of snakegourd fruit and folium ginkgo |
10/13/2010 | CN101125882B Recombination PAC1 receptor agonist RMMAX and its expression method and application |
10/13/2010 | CN101117630B Preparation method of nattokinase powder and natto Brazil mushroom capsule |
10/13/2010 | CN101069557B Health-care blood-sugar-reducing food and preparing method |
10/13/2010 | CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
10/13/2010 | CN101007115B 'Qihong' oral liquid |
10/12/2010 | US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses |
10/12/2010 | US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids |
10/12/2010 | US7812159 Processes for preparing aromatic ethers |
10/12/2010 | US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid |
10/12/2010 | US7812004 For modifying and modulating the bacterial flora and the fermentation pattern of inulin in the large intestine; anticancer agents; dietary fibre effects, improved mineral absorption (calcium and magnesium), for treating osteoporosis |
10/12/2010 | US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell |
10/12/2010 | US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation |
10/12/2010 | CA2480038C Substituted 4-aminocyclohexanols |
10/12/2010 | CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method |
10/12/2010 | CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
10/12/2010 | CA2410556C Konjac mannan and polysaccharide compositions and uses thereof |
10/12/2010 | CA2407149C Melanin-concentrating hormone antagonist |
10/12/2010 | CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect |
10/12/2010 | CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
10/12/2010 | CA2320402C Modified ciliary neurotrophic factor, method of making and methods of use thereof |
10/07/2010 | WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof |
10/07/2010 | WO2010114957A1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders |
10/07/2010 | WO2010114215A2 Composition for preventing or treating obesity, dyslipidemia, fatty liver or insulin resistance syndrome, comprising camphor as an active ingredient |
10/07/2010 | WO2010113860A1 Biphenyl-cyclic amine compound |
10/07/2010 | WO2010113841A1 Orally disintegrating coated tablet |
10/07/2010 | WO2010113834A1 Pyrimidine compound |
10/07/2010 | WO2010113785A1 Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced |
10/07/2010 | WO2010113631A1 Agent for amelioration or prevention of metabolic syndrome |
10/07/2010 | WO2010112520A1 Spiro derivatives for the modulation of stearoyl-coa desaturase |
10/07/2010 | WO2010112429A1 Reduction of risk of obesity |
10/07/2010 | WO2010112256A1 Satiety-inducing composition |
10/07/2010 | WO2010111905A1 Pharmaceutical composition for treatment of 2 type dabetes |
10/07/2010 | WO2010111759A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin |
10/07/2010 | WO2010091067A3 Derivatives of [1, 3] oxazin- 2-one useful for the treatment of metabolic diseases such as lipid disorders |
10/07/2010 | WO2010088897A3 Plant extracts for regulating body weight |
10/07/2010 | WO2010081862A3 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine) |
10/07/2010 | WO2010079910A3 Eyesight-protecting composition containing functional components having preventive and therapeutic efficacy in diabetes or diabetes complications |
10/07/2010 | WO2010059662A9 Constitutive androstane receptor (car) as a therapeutic target for obesity and type two diabetes |
10/07/2010 | WO2010019435A3 Solid states of atorvastatin potassium |
10/07/2010 | US20100256235 Dietary formulations and methods for treatment of inflammation and other disorders |
10/07/2010 | US20100256220 PAS Kinase Regulates Energy Homeostasis |
10/07/2010 | US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor |
10/07/2010 | US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |